RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease
RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease have?
RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease has 77 citations in the OpenAlex counts ScholarIQ stores.
When was RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease published?
RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease has 2017 year in the ScholarIQ index.
What is the open-access status of RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease?
RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease has gold oa status in the ScholarIQ index.
What is the DOI of RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease?
The DOI for RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease is on the source record.
What is the PMID of RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease?
The PMID for RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease is on the source record.
What is the OpenAlex record for RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease?
The OpenAlex for RIG‐I antiviral signaling drives interleukin‐23 production and psoriasis‐like skin disease is on the source record.